3Kiviharju TM,Lecane PS,Sellers RG,et al. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res,2002, 8:2666-2674.
4Zhao G, Vaszar LT, Qiu D, et al. Anti-inflammatory effects of triptolide in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol, 2000, 279: L958-L966.
5Shamon LA, Pezzuto JM, Graves J M, et al. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett, 1997,112: 113-117.
6Zheng Ch, Zheng X, Bian ZC, et al. Differtial regulation of PyK2 and focal adhesion kinase(FAK) [J]. Biol Chem, 1998,273: 2384～2389.
7Yang S, Chen J, Guo Z, et al. Triptolide inhibits the growth and metastasis of solid tumor[J]. Mol Cancer Ther, 2003, 2 (1) : 65～72.
8Chary I,Rozengur E. Focal adhesion kinase(p125FAK): a point of convergence in the action of neuropeptides, intergrins and oncogenes[J]. Cell, 1992,71:891～894.
9Han HM, Fleming RY, Curley SA, et al. Overexpression of foal adhesion kinase (P125FAK) in human colorectal carcinoma liver metastasis: independence from c-src or c-yes activation [J]. Ann Surg Oncol, 1997,4 (3): 264～268.
10Owens LV, Xu L, Dent GA, et al. Focal adhesion kinase as a marker of invasive potential in differentiated human throid cancer [J]. Ann Surg Oncol, 1996,3(1): 100～105.
